IBIO · Forms 3, 4, 5
Insider trades at iBio, Inc.
No open-market insider buys or sells at iBio, Inc. in the last 90 days; 8 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for iBio, Inc. (IBIO) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Elizabeth Stoner | Director | Options or other derivatives | Form 4 | ||||
| Alexandra Kropotova | Director | Options or other derivatives | Form 4 | ||||
| David Arkowitz | Director | Options or other derivatives | Form 4 | ||||
| William D Clark | Director | Options or other derivatives | Form 4 | ||||
| Antonio Bernardino Guimaraes Parada | Director | Options or other derivatives | Form 4 | ||||
| Gary Sender | Director | Options or other derivatives | Form 4 | ||||
| Molly Carr | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Molly Carr | Chief Medical Officer | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.